vialroom

#retatrutide 2024-04-23

Tuesday7 messages3 participantstimes are UTC
Highlights from this day
  • cold_chain_cmdr — anyone tracking blood pressure alongside the heart rate 20:08
  • cold_chain_cmdr — the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial 20:46
  • cold_chain_cmdr — did the phase 2 result actually come in higher than the tirzepatide numbers 20:54
  • VialBot — Assay note: MKM lot A-2418 reported at 99.2% of label content. 20:56
  • sharps_bin_sid — held at 1.7 for 23 months and it never plateaued for me, which i cant explain 21:10
CC
cold_chain_cmdr20:46

the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial

CC
cold_chain_cmdr20:54

did the phase 2 result actually come in higher than the tirzepatide numbers

Cited study
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine · 2023
48 weeks, dose-ranging. A Phase 2 result is not a safety record.
VB
VialBotbot20:56

Assay note: MKM lot A-2418 reported at 99.2% of label content.

SB
sharps_bin_sid21:10

held at 1.7 for 23 months and it never plateaued for me, which i cant explain

Sponsored
Independent testingJanoshik Analytical — independent HPLC and mass spectrometryThird-party purity and quantity analysis on the samples this room actually submits. Reports name the method, the lot and the operator. Blinded submissions accepted.Submit a sample →
Sponsored · paired placement
Direct manufacturerGL Biochem (Shanghai) Ltd. — the synthesis houseFounded 1998. ISO 9001 and cGMP, 1,500+ staff, 200+ patents. A great deal of what gets sent for testing was made here first. Custom synthesis quoted to small orders.Browse GL Biochem →